Sanofi opens new Framingham facility
Courtesy | Sanofi
Sanofi's new Framingham facility is the company's first digitally born facility.
Sanofi will celebrate the grand opening of a new manufacturing facility in Framingham today in a ceremony that will be attended by Gov. Charlie Baker.
The facility at 8 New York Ave. in Framingham will keep the company in the city while Sanofi builds a 900,000-square-foot complex in Cambridge to consolidate much of its Massachusetts operations. That facility is expected to open in 2021, but the company has said it will retain a presence in Framingham.
The new Framingham building will not create any new jobs, however the company has held training of some of its 1,500 person local workforce to make use of the new facility.
The new facility features technology that connects the production process with research and development, with the goal of improved commercialization of new medicines for patients. The goal is to reduce the time it takes products to move from development to manufacturing. According to Sanofi, the new facility has the potential to make medicines at double the rate of a traditional factory.
Framingham is the first "digitally born" facility, according to Sanofi, while similar digital transformations will be introduced in other legacy plants. Sanofi intends to move forward with digital transformation initiatives in Toronto (Canada), Suzano (Brazil), Waterford (Ireland), Sisteron (France) and Geel (Belgium).
Genzyme, which is owned by Sanofi, sold two Framingham office buildings on nearby Mountain Road for about $20.5 million in May. Genzyme said it will remain at the offices in a sale-leaseback agreement. Sanofi also has offices at One Research Drive in Westborough that may be affected by the planned consolidation in Cambridge.
WBJ Web Partners
Most Recent
Most Recent
0 Comments